Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

LGVN | Longeveron Inc

Index- P/E- EPS (ttm)-0.95 Insider Own48.19% Shs Outstand52.73M Perf Week0.92%
Market Cap115.48M Forward P/E- EPS next Y-0.79 Insider Trans-0.09% Shs Float27.32M Perf Month-13.10%
Income-19.98M PEG- EPS next Q-0.23 Inst Own1.52% Short Float / Ratio1.71% / 3.70 Perf Quarter-39.36%
Sales0.88M P/S131.23 EPS this Y-2.22% Inst Trans4.24% Short Interest0.47M Perf Half Y-20.94%
Book/sh0.54 P/B4.08 EPS next Y14.13% ROA-75.94% Target Price14.15 Perf Year-44.84%
Cash/sh0.16 P/C13.33 EPS next 5Y- ROE-97.83% 52W Range2.12 - 4.81 Perf YTD-31.99%
Dividend- P/FCF- EPS past 5Y-28.28% ROI-152.38% 52W High-54.47% Beta0.74
Dividend %- Quick Ratio2.52 Sales past 5Y20.19% Gross Margin-84.58% 52W Low3.30% ATR0.21
Employees19 Current Ratio2.52 Sales Q/Q-53.43% Oper. Margin-2364.40% RSI (14)37.26 Volatility6.82% 10.78%
OptionableNo Debt/Eq0.21 EPS Q/Q0.63% Profit Margin-2265.19% Rel Volume0.20 Prev Close2.18
ShortableYes LT Debt/Eq0.15 EarningsAug 11 BMO Payout- Avg Volume126.45K Price2.19
Recom1.00 SMA20-8.16% SMA50-23.62% SMA200-31.27% Volume15,580 Change0.46%
Sep-12-23 09:00AM
Sep-11-23 08:00AM
Sep-07-23 08:30AM
08:00AM
Sep-05-23 08:00AM
07:00AM Loading…
07:00AM
Aug-29-23 08:00AM
Aug-22-23 08:00AM
Aug-16-23 09:13AM
Aug-14-23 04:05PM
08:00AM
Aug-11-23 07:30AM
07:24AM
07:00AM
Aug-08-23 09:25AM
07:00AM Loading…
07:00AM
Aug-07-23 08:00AM
Jul-20-23 08:00AM
Jul-11-23 08:00AM
Jul-10-23 08:00AM
Jul-07-23 09:00AM
Jul-06-23 11:12AM
Jun-27-23 06:07PM
Jun-13-23 08:30AM
May-12-23 08:32AM
08:20AM
08:00AM
May-09-23 05:23PM
08:30AM
May-08-23 08:30AM
08:59AM Loading…
Apr-19-23 08:59AM
Mar-14-23 02:38PM
Mar-10-23 08:00AM
06:10AM
Mar-07-23 04:18PM
Mar-06-23 08:30AM
Feb-28-23 08:30AM
Jan-27-23 08:51AM
Jan-19-23 08:35AM
08:30AM
Jan-06-23 09:58AM
08:30AM
Nov-29-22 04:30PM
Nov-16-22 05:32AM
Nov-14-22 08:00AM
07:15AM
Nov-10-22 08:30AM
Nov-07-22 09:06AM
Oct-05-22 02:34PM
11:00AM
08:30AM
Sep-15-22 08:30AM
Sep-06-22 08:30AM
Aug-31-22 08:30AM
07:30AM
Aug-25-22 08:00AM
07:30AM
Aug-20-22 08:45AM
Aug-12-22 08:00AM
07:36AM
Aug-08-22 08:30AM
Jul-27-22 09:33AM
Jul-07-22 08:00AM
Jun-26-22 10:22AM
May-21-22 10:16AM
May-13-22 08:00AM
07:12AM
May-09-22 04:15PM
08:30AM
Apr-28-22 01:53PM
Apr-14-22 08:58AM
Apr-13-22 08:00AM
07:30AM
Apr-08-22 05:02PM
Apr-05-22 08:00AM
Apr-01-22 06:30AM
Mar-31-22 08:00AM
07:48AM
07:30AM
Mar-24-22 08:00AM
Mar-15-22 04:54PM
08:00AM
Mar-11-22 08:00AM
06:10AM
Mar-07-22 08:00AM
Mar-02-22 08:00AM
Feb-17-22 08:00AM
Jan-27-22 05:38PM
04:49PM
Jan-26-22 09:10AM
Jan-25-22 08:00AM
Jan-17-22 07:32AM
Jan-12-22 08:00AM
Jan-05-22 12:16PM
08:00AM
Jan-04-22 08:00AM
Dec-17-21 01:50PM
Dec-10-21 01:32PM
Dec-09-21 06:45AM
Dec-07-21 01:51PM
Longeveron, Inc. is a clinical stage biotechnology company. It engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hare JoshuaChief Scientific OfficerSep 21Option Exercise3.005,00015,0007,828,263Sep 22 07:00 PM
Lehr Paul TGeneral Counsel, SecretarySep 20Option Exercise3.002,0006,000144,213Sep 21 05:00 PM
Hare JoshuaChief Scientific OfficerSep 12Option Exercise3.0030,00090,0007,823,263Sep 14 05:09 PM
Hashad Mohamed Wa'el AhmedChief Executive OfficerSep 12Option Exercise3.0010,00030,00047,566Sep 13 05:00 PM
Soffer RockDirectorSep 08Option Exercise3.0030,00090,000702,351Sep 12 05:00 PM
Clavijo JamesCFO and TreasurerJun 29Sale3.515,00017,55047,303Jun 29 05:00 PM
Clavijo JamesCFO and TreasurerJun 28Sale3.4310,00034,30052,303Jun 29 05:00 PM
Clavijo JamesCFO and TreasurerJun 27Sale3.488,53229,69162,303Jun 29 05:00 PM
Hare JoshuaChief Scientific OfficerJan 27Sale4.2820,00085,6007,793,263Jan 30 05:00 PM
Hare JoshuaChief Scientific OfficerDec 02Sale3.7420,00074,8007,813,263Dec 05 05:00 PM
Hare JoshuaChief Scientific OfficerOct 12Sale3.61100,000361,0007,813,263Oct 18 05:01 PM